AI methods for automated identification of regions of inflammation from ⁹⁹ᵐTc-Maraciclatide imaging presented at the World Molecular Imaging Congress 2023 By Designer AI methods for automated identification of regions of inflammation from ⁹⁹ᵐTc-Maraciclatide imaging presented at the World Molecular Imaging Congress 2023 Read More »
Icahn School of Medicine at Mount Sinai commences clinical testing with Seracam® By Designer Icahn School of Medicine at Mount Sinai commences clinical testing with Seracam® Read More »
James Kaufman appointed as Chief Commercial Officer By Designer James Kaufman appointed as Chief Commercial Officer Read More »
First US site commences clinical testing of Seracam® By Designer First US site commences clinical testing of Seracam® Read More »
Initial Seracam® characterization results presented at BNMS Spring Meeting, Harrogate By Designer Initial Seracam® characterization results presented at BNMS Spring Meeting, Harrogate Read More »
First clinical testing of Seracam® commences at the University of Malaya By Designer First clinical testing of Seracam® commences at the University of Malaya Read More »
Seracam® to be presented at Parathyroid Symposium 2023: Oral presentation on qualitative and quantitative capabilities and novel features of Seracam® By Designer Seracam® to be presented at Parathyroid Symposium 2023: Oral presentation on qualitative and quantitative capabilities and novel features of Seracam® Read More »
Initial Seracam® characterization results presented at Cancer Diagnosis Network Theranostics Workshop By Designer Initial Seracam® characterization results presented at Cancer Diagnosis Network Theranostics Workshop Read More »
Generative Modelling methods for ⁹⁹ᵐTc-Maraciclatide presented at the Institute of Electrical and Electronics Engineers (IEEE) Medical Imaging Conference 2022 By Designer Generative Modelling methods for ⁹⁹ᵐTc-Maraciclatide presented at the Institute of Electrical and Electronics Engineers (IEEE) Medical Imaging Conference 2022 Read More »
Serac Healthcare Partners with University of Oxford to Evaluate the Potential of ⁹⁹ᵐTc-Maraciclatide to Diagnose Endometriosis Non-Invasively By Designer Serac Healthcare Partners with University of Oxford to Evaluate the Potential of ⁹⁹ᵐTc-Maraciclatide to Diagnose Endometriosis Non-Invasively Read More »
